Filing Flows › BrightSpring Health Services (BTSG) › Guidance & outlook
BrightSpring Health Services (BTSG) guidance and outlook
BrightSpring Health Services (BTSG) raised its guidance on Oct 30, 2026: Revenue $15.9B–$16.1B for FY2026; Revenue +23.2% to +24.9% for FY2026; EBITDA $850M–$860M for FY2026; EBITDA +37.6% to +39.3% for FY2026.
Guidance and outlook
Latest guidance
| Metric | Period | Range | Change |
|---|---|---|---|
| Revenue | FY2026 | $15.9B–$16.1B | raised |
| Revenue | FY2026 | +23.2% to +24.9% | raised |
| Revenue | FY2026 | $14.0B–$14.2B | new |
| Revenue | FY2026 | +22.3% to +24.1% | new |
| EBITDA | FY2026 | $850M–$860M | raised |
| EBITDA | FY2026 | +37.6% to +39.3% | raised |
From the earnings release filed Oct 30, 2026 (8-K on EDGAR).
BrightSpring Health Services' latest quarter
BrightSpring Health Services, Q3 2026: revenue $4.2B (+26% year over year), operating margin 3.8%, net earnings $100M, operating cash flow $204M. The chart follows the revenue to costs, profit and cash.
Questions
Did BrightSpring Health Services raise or lower its guidance?
BrightSpring Health Services (BTSG) raised its guidance on Oct 30, 2026: Revenue $15.9B–$16.1B for FY2026; Revenue +23.2% to +24.9% for FY2026; EBITDA $850M–$860M for FY2026; EBITDA +37.6% to +39.3% for FY2026.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.